U.S. and World Newswire
:
Medical
:
Drugs and Pharmaceuticals
News
Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product
Published: Mon, 06 Aug 2007, 19:46:00 EDT
RICHMOND, Texas - Aug. 6 (SEND2PRESS NEWSWIRE) -- CYNACON/OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.
The ALODOX(R) Convenience Kit contains ALODOX(R) (Doxycycline Hyclate 20 milligrams); OCuSOFT(R) Lid Scrub(TM) PLUS Extra Strength Pre-Moistened Pads; and OCuSOFT(R) Lid Scrub(TM) Original Foaming Eyelid Cleanser. This new and convenient combination therapy promises to significantly increase patient compliance while improving overall eyelid-hygiene therapy.
OCuSOFT(R) Lid Scrub(TM) PLUS Extra Strength Pre-Moistened Pads is an extra strength eyelid cleanser that uses a low-level preservative and moisturizer blend, offering a wide range of anti-bacterial properties. It is perfect for moderate to severe eyelid conditions.
OCuSOFT(R) Lid Scrub(TM) Original Foaming Eyelid Cleanser is an instant foam liquid that generates pre-lathered foam immediately upon depressing the control-tip pump. The foam formula provides patients who are on a lid-hygiene regimen, with added convenience. It is economical and ideal for shower use.
So, why combine all three? Reports confirm that ALODOX(R) is prescribed much more often than minocycline, partly because it is a more potent collagenase inhibitor.
Therefore, the use of low-dose doxycycline hyclate has demonstrated effective enzyme modulation treatment of inflammatory disease. And, at such low levels - 50 milligrams or less - doxycycline reduces inflammation, yet still maintains maximum plasma drug concentrations below the anti-microbial threshold, resulting in fewer side effects.
"We are excited to be able to offer the ALODOX Convenience Kit for systemic inflammatory relief," Patrick Witham, Executive Vice President, CYNACON/OCuSOFT(R), said. "While traditional doxycycline has been prescribed for years, new research suggests that low-dose doxycycline is just as effective, and without the added side effects such as gastritis and photosensitivity."
Coupled with OCuSOFT(R) Lid Scrub(TM) products, the ALODOX(R) Convenience Kit has a mission that will lead to increased patient satisfaction and compliance.
CYNACON/OCuSOFT(R) (OCuSOFT, Inc.), founded in 1986, is a company dedicated to addressing clinical needs through well-researched and technological solutions. They are dedicated to optimizing the delivery and performance of ophthalmic pharmaceutical products while improving patient care, quality of life, and compliance.
For more information on the ALODOX(R) Convenience Kit, visit: www.alodox.com. To learn more about the company and find out about other available products, visit: www.ocusoft.com.
NEWS SOURCE: CYNACON / OCuSOFT (OCuSOFT, Inc.)
Send2Press® is the originating wire service for this story.
» Read More Drugs and Pharmaceuticals News
» Other Send2Press Industry News by Category
More Information and Media Contact:
For questions about this story, contact the news source:
»
Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).
O T H E R R E S O U R C E S
T E R M S O F U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article.
News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (CYNACON / OCuSOFT (OCuSOFT, Inc.)). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product, CYNACON OCuSOFT, ALODOX Convenience Kit, ophthalmic research, development and supply to ophthalmologists and optometrists, OCuSOFT Inc, Original Foaming Eyelid Cleanser, Doxycycline Hyclate, collagenase inhibitor, Patrick Witham, eyelid-hygiene therapy, Aug 6, 2007.
VIEWED BY MEDIA (and public): 1607 times (2 today, 25 this week,
21 this month, 751 this year)
|
 |
|